Lacking investors, Waltham medical firm delays its IPO
BG Medicine, a small Waltham company trying to develop novel medical tests, has postponed its initial public offering until next year after failing to excite enough investors to go public this month, analysts say. (Full article: 436 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
